TERT and liver cancer: Previous report indicated that TERT promoter mutations in tissue of cirrhosis correlate with the rate of hepatocarcinogenesis, with mutations identified in 6% of low grade dysplastic nodules, 19% of high grade dysplastic nodules, and 61% of early liver cancer [17].